UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037658
Receipt number R000042944
Scientific Title Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy
Date of disclosure of the study information 2019/08/22
Last modified on 2019/08/10 15:00:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy

Acronym

Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy

Scientific Title

Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy

Scientific Title:Acronym

Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy

Region

Japan


Condition

Condition

Gastroenterology outpatients undergoing colonoscopy

Classification by specialty

Gastroenterology Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will compare and consider the taking method (standard method and two cups method) so that patients can take oral intestinal cleanser used for pretreatment of colonoscopy without pain.

Basic objectives2

Others

Basic objectives -Others

By comparing and examining how to take the oral intestinal cleanser used in colonoscopy, it becomes a pretreatment that can alleviate the pain and anxiety of the patient.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Ease of drinking Movi prep (taste, amount, water consumption)
Comprehension of how to medication

Key secondary outcomes

Cleaning effect evaluation
Mobiprep dose
Water consumption


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Standard method for oral intestinal cleanser

Interventions/Control_2

two cup one cup methodfor oral intestinal cleanser

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Gastroenterological outpatients undergoing colonoscopy and patients with consent

Key exclusion criteria

Person who can not obtain consent

Target sample size

480


Research contact person

Name of lead principal investigator

1st name Yoshiko
Middle name
Last name Hayashi

Organization

Aoyama General Hospital

Division name

Outpatient

Zip code

441-0195

Address

100-1, Doji Kozakai, Toyokawa, Aichi,Japan

TEL

+81-533-73-3777

Email

gairai@aoyama-hp.or.jp


Public contact

Name of contact person

1st name Mayumi
Middle name
Last name Kato

Organization

Aoyama General Hospital

Division name

Outpatient

Zip code

441-0195

Address

100-1, Doji Kozakai, Toyokawa, Aichi,Japan

TEL

+81-533-73-3777

Homepage URL


Email

cnic-kato@aoyama-hp.or.jp


Sponsor or person

Institute

Aoyama General Hospital
Nursing department

Institute

Department

Personal name



Funding Source

Organization

Aoyama General Hospital
Nursing department

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aoyama General Hospital Ethics Committee

Address

100-1, Doji Kozakai, Toyokawa, Aichi,Japan

Tel

+81-533-73-3777

Email

ijika@aoyama-hp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

総合青山病院(愛知県)
Aoyama General Hospital (Aichi)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 07 Month 25 Day

Date of IRB

2019 Year 08 Month 10 Day

Anticipated trial start date

2019 Year 09 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 04 Month 30 Day

Date trial data considered complete

2020 Year 04 Month 30 Day

Date analysis concluded

2020 Year 05 Month 30 Day


Other

Other related information



Management information

Registered date

2019 Year 08 Month 10 Day

Last modified on

2019 Year 08 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042944


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name